Quote this publication Share Print

ABILIFY

-
Opinions on drugs - Posted on Mar 19 2013

Reason for request

Re-assessment of the Actual Benefit and Improvement in Actual Benefit in accordance with article R-163-21 of the Social Security Code.

-


Actual benefit

Important

The actual benefit of ABILIFY in the treatment of schizophrenia remains substantial.


Improvement in actual benefit

III (modéré)

ABILIFY, like all other antipsychotics (including typical antipsychotics), provides a moderate improvement in actual benefit (IAB III) to the management of schizophrenia.


Contact Us

Évaluation des médicaments

See also